background approximately NUMBER people north america carry piz defect gene encoding serum protein alpha aat homozygotes subject early onset emphysema liver disease demonstrate means correcting gene defect point mutation chromosome NUMBER targeted homologous recombination experimental design target recombination aat locus human cells use normal complementary dna cleaved approximately NUMBER base pairs upstream piz mutation site exon v transfection targeting monitored using polymerase chain reaction assay devised uniquely amplify successful homologous recombinants results excercised human pizz gm2522 fibroblasts targeting replaces exon v endogenous gene containing piz mutation exon v counterpart normal complementary dna simultaneously displacing mutated exon v away promoter reversing targeting strategy using human pim hepatoma cells able supplant normal copy aat gene mutated piz version allowed culture human hepg2 cells expressing pathologic phenotype piz defect immunocytologic staining demonstrates presence inclusions liver cells aggregation piz isoform encoded recombined aat gene control endogenous gene promoter conclusions targeting aat locus observed using methods developed rates render feasible selection targeted cells isolation clones bearing corrected aat gene b correction exon v piz mutation regardless accompanying exon iii mutation sufficient prevent aggregation piz protein human liver cells c targeted homologous recombination offers advantages potential gene therapy correct aat defects NUMBER antitrypsin